![]() |
市場調查報告書
商品編碼
2016060
醫用導管市場報告:按產品、結構、應用、最終用戶和地區分類(2026-2034 年)Medical Tubing Market Report by Product, Structure, Application, End User, and Region 2026-2034 |
||||||
2025年全球醫用導管市場規模達153億美元。展望未來,IMARC Group預測,到2034年,該市場規模將達到254億美元,2026年至2034年的複合年成長率為5.63%。癌症、關節炎和心血管疾病的日益普遍,以及醫用導管在導管插入術中的廣泛應用,正在推動市場成長。
對微創手術的需求日益成長
微創手術需求的不斷成長無疑是醫用導管市場成長的主要推動因素。例如,根據2022年1月發表的題為《微創手術的未來:微電子導管》的報導,導管在微創手術中發揮著至關重要的作用,它們能夠輔助血栓清除、植入植入或將藥物精準輸送到所需位置。此外,導管的設計旨在減輕患者的負擔。醫用導管在醫療領域的各種應用中也扮演著極為重要的角色,包括外科手術、診斷流程、藥物傳遞系統和靜脈輸液治療。隨著醫療技術的不斷進步,對專用和先進醫用導管的需求也在不斷成長。例如,2023年9月,全球解決方案供應商Zeus公司推出了其生物可吸收產品線中的最新產品-Absorv™ XSE定向導管。 Absorv XSE是一個高度靈活的設計平台,為永久植入人體的金屬產品提供了一種替代方案。它有多種樹脂材料可供選擇,尺寸範圍也更廣。此外,全球人口老化和慢性病發病率的上升也增加了侵入性治療的需求。心血管疾病、癌症和神經系統疾病等疾病通常需要藉助醫療導管進行干預,以確保治療藥物的精準輸送。例如,根據MD安德森癌症中心2024年4月發表的報導,如果頭頸癌患者出現吞嚥困難,或在癌症治療(包括手術、化療和放射線治療)前後營養不良,可能需要腸內營養管。這些因素進一步推動了醫療導管市場佔有率的擴大。
人口老化的進程
隨著預期壽命的延長,老年人口顯著成長。例如,根據世界衛生組織(世衛組織)的數據,60歲及以上人口正在增加。 2019年,60歲以上人口已達10億人。預計到2030年,這一數字將增加至14億,到2050年將達到21億。隨著老年人口的成長,對各種醫療服務和設備的需求也在增加,其中包括使用醫用導管的醫療服務和設備。醫用導管用途廣泛,包括靜脈輸液管、導尿管、呼吸管和腸內營養管等,老年人通常需要使用醫用導管來管理各種健康問題。美國國家醫學圖書館發表的報導指出,由於吞嚥困難和營養不良,鼻飼管餵食在老年人(65歲及以上)中很常見。老年人的吞嚥困難通常是由多種因素造成的。此外,隨著人口老化,對持續醫療保健和支援的需求日益成長,導致醫用導管產品的需求量增加。同時,醫療技術的進步也催生了用於各種醫療程序的專用導管,進一步擴大了醫用導管市場的收入。例如,2022年12月,弗羅伊登貝格醫療在CPhl和PMEC印度展會上發布了其新產品「HelixFlex」。本產品是一種高純度熱可塑性橡膠(TPE)導管,專為生物製藥的流體輸送而設計。
慢性病激增
心血管疾病、糖尿病和癌症等慢性疾病的發生率正急劇上升,進一步推動了對醫用導管的需求。根據健康指標與評估研究所 (IHME) 於 2023 年 6 月發布的報告,糖尿病影響著世界各地各個年齡層的男性、女性和兒童,全球整體患者人數超過 5 億。預計未來 30 年,這一數字將翻倍以上,達到 13 億,並且預計所有國家的患者人數都將增加。醫用導管不僅在藥物、液體和營養的輸注方面發揮著至關重要的作用,而且在這些疾病的監測和管理中也扮演著重要角色。此外,許多慢性疾病需要持續用藥來控制症狀、延緩疾病進展或預防併發症。這些因素影響了近期醫用導管市場的價格趨勢。醫用導管,例如靜脈輸液管和輸液器,能夠安全有效地輸注藥物,包括化療藥物、胰島素、抗生素和止痛藥。例如,根據帕金森氏症基金會2022年的最新數據,預計美國每年將有9萬人被診斷出患有帕金森氏症(PD),到2030年,預計美國將有約120萬人患有此病。因此,腦細胞將不再吸收左旋多巴,也無法儲存多巴胺,導致難以控制患者的症狀。在正確的時間給藥至關重要,而靜脈輸液療法可以更持續地輸送藥物,從而更穩定、更可靠地緩解症狀。這些因素進一步對醫用導管市場的前景產生了正面影響。
The global medical tubing market size reached USD 15.3 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 25.4 Billion by 2034, exhibiting a growth rate (CAGR) of 5.63% during 2026-2034. The rising prevalence of cancer, arthritis, and cardiovascular conditions, along with the widespread usage of medical tubing in catheterization, is propelling the market growth.
Rising Demand for Minimally Invasive Procedures
The increasing demand for medically invasive procedures indeed contributes significantly to the growth of the medical tubing market. For instance, according to the January 2022 article "Microelectronic Catheter for Minimally Invasive Surgery of the Future," catheters play a major role in minimally invasive surgery because they make it easy to remove blood clots, insert implants, or administer drugs precisely where they are needed. They are also designed to be especially gentle on patients. Moreover, medical tubing plays a crucial role in various applications within healthcare settings, including surgical procedures, diagnostic processes, drug delivery systems, and intravenous therapies, among others. As advancements in medical technology continue to evolve, the need for specialized and advanced medical tubing also rises. For instance, in September 2023, Zeus, an advanced polymer solutions provider around the world, created AbsorvTM XSE oriented tubing, the newest addition to its line of bioabsorbable products. Absorv XSE is a highly adjustable platform for design that offers an alternative to metallic items implanted permanently in the human body. It is available in a variety of resins and increased size ranges. Moreover, the aging population and the increasing prevalence of chronic diseases worldwide contribute to the demand for invasive procedures. Conditions, such as cardiovascular diseases, cancer, and neurological disorders often require interventions that rely on medical tubing for precise delivery of treatments. For instance, according to the article published by MD Anderson Cancer Center in April 2024, cancer patients might need a feeding tube if they have trouble swallowing due to cancer in the head or neck area or are malnourished before or during cancer treatment, including surgery, chemotherapy, and radiation therapy. These factors are further contributing to the medical tubing market share.
Increasing Geriatric Population
The aging population is increasing significantly owing to longer life expectancy. For instance, according to the World Health Organization, the number of people aged 60 and up in the population is increasing. In 2019, there were one billion people aged 60 and over. This figure will rise to 1.4 billion by 2030, and 2.1 billion by 2050. As the elderly population grows, there's an increased demand for various medical services and devices, including those that utilize medical tubing. Medical tubing is used in a wide range of applications, such as intravenous (IV) lines, catheters, respiratory tubing, and feeding tubes, which are commonly required by older individuals for managing various health conditions. According to an article published by the National Library of Medicine, nasogastric feeding is often used in elderly patients (over the age of 65) due to dysphagia and malnutrition. Dysphagia in older adults is usually multifactorial. Moreover, the aging population often requires ongoing medical care and support, leading to higher consumption of medical tubing products. Additionally, advancements in medical technology have led to the development of specialized tubing for different medical procedures, thereby further bolstering the medical tubing market revenue. For instance, in December 2022, Freudenberg Medical launched a new product, HelixFlex, at the CPhl and PMEC India. The product is a high-purity thermoplastic elastomer TPE tubing intended for use in biopharmaceutical fluid transfer applications.
Surging Incidences of Chronic Diseases
The incidence of chronic diseases such as cardiovascular, diabetes, cancer, etc., is experiencing a significant surge, thereby further driving the demand for medical tubing. According to a report published by the Institute for Health Metrics and Evaluation in June 2023, in every country, men, women, and children of all ages are affected by diabetes, which affects more than half a billion people globally. In the next 30 years, that figure is expected to more than double to 1.3 billion people, with an increase in every country. Medical tubing plays a crucial role in the delivery of medications, fluids, and nutrition, as well as in monitoring and managing these conditions. Moreover, many chronic conditions require ongoing medication to manage symptoms, control disease progression, or prevent complications. These factors are influencing the medical tubing market's recent prices. Medical tubing, such as intravenous (IV) lines and infusion sets, facilitates the safe and efficient delivery of medications, including chemotherapy drugs, insulin, antibiotics, and pain relievers. For instance, according to the Parkinson's Foundation's 2022 data update, 90,000 individuals in the U.S. are expected to receive a PD diagnosis each year, and by 2030, about 1.2 million Americans are expected to have the disease. In line with this, it gets difficult to control the symptoms when someone is suffering from this disease as brain cells don't absorb levodopa and store dopamine. It becomes crucial to take the drug during the time, infusion therapy delivers medication more continuously and provides more consistent and reliable symptom relief. These factors are further positively influencing the medical tubing market forecast.
Currently, polyvinyl chloride holds the majority of the total market share
According to the medical tubing market overview, polyvinyl chloride (PVC) medical tubing finds widespread usage across various medical applications due to its favorable properties, such as flexibility, durability, biocompatibility, and affordability. PVC tubing is extensively used in IV therapy for delivering fluids, medications, and blood products directly into the bloodstream. It is available in various lengths and diameters to accommodate different clinical needs. As healthcare spending continues to rise globally, there's a parallel demand for PVC medical tubing. Moreover, PVC tubing is often preferred for its cost-effectiveness compared to other materials like silicone or polyurethane, especially in applications where disposable tubing is used, further driving its adoption. For instance, in May 2021, Benvic, a PVC compound and ecological biopolymers specialist, announced that it would use its ModenPlast subsidiary in Northern Italy to look for material synergies and innovative products for the global medical markets.
Single-Lumen tubing consists of a single hollow channel and is commonly used in applications where a single fluid or gas needs to be transported, such as in IV lines, oxygen delivery systems, or simple drainage tubes. While co-extruded tubing involves the simultaneous extrusion of multiple layers of materials with different properties. Moreover, multi-lumen tubing contains multiple channels within the same tube. It is commonly used in medical devices where separate channels are needed for various functions, such as in catheters with separate lumens for medication delivery. Furthermore, tapered or bump tubing is designed with a gradual decrease or increase in diameter along its length, creating a tapered or bump feature. Also, braided tubing consists of multiple layers of materials with fibers braided around the inner tube. This construction provides increased strength, kink resistance, and burst pressure compared to non-braided tubing.
Bulk disposable tubing currently exhibits a clear dominance in the market
As per the medical tubing market overview, bulk disposable tubing offers cost advantages due to its mass production and single-use nature. Healthcare facilities can purchase these tubes in large quantities at competitive prices, reducing overall expenses. Moreover, disposable tubing minimizes the risk of cross-contamination and nosocomial infections compared to reusable tubing. After a single use, the tubing is discarded, eliminating the need for sterilization and reducing the chances of transmitting pathogens between patients. Furthermore, this tubing meets stringent regulatory requirements for medical devices, ensuring adherence to quality and safety standards. Manufacturers produce disposable tubing using materials that comply with regulatory standards for biocompatibility and sterility, providing reassurance to healthcare providers and patients. For instance, in November 2020, Olympus partnered with Ruhof Corporation to launch the Olympus Procedure Kits, and Hybrid Tubing, two new single-use and single-day devices that alleviate the possibility of cross-contamination.
Currently, hospitals and clinics account for the largest market share
Hospitals and clinics are primary settings for patient care and treatment, where medical tubing is extensively used in various medical procedures and therapies. From intravenous therapy and respiratory support to surgical interventions and diagnostic procedures, medical tubing plays a vital role in delivering fluids, medications, and gases to patients. Moreover, hospitals and clinics require medical tubing for a diverse range of applications across different departments and specialties. This includes intravenous administration sets, catheters, drainage tubes, endotracheal tubes, feeding tubes, and more. Each department within a hospital, such as emergency, intensive care, surgery, and obstetrics, relies on specific types of tubing tailored to their clinical needs. For instance, in November 2023, the Medical Research Council awarded the University of Nottingham £1.1 million to conduct human trials for the world's first endotracheal tube integrated with an optical fiber sensor.
North America currently dominates the global market
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America currently dominates the global market.
According to the medical tubing market statistics, North America boasts one of the highest healthcare expenditures globally. The continuous rise in healthcare spending, driven by factors such as an aging population, increasing prevalence of chronic diseases, and advancements in medical technology, contribute significantly to the growth of the medical tubing market. The region is a hub for medical innovations and technological advancements. Moreover, manufacturers are constantly developing new materials, designs, and manufacturing processes to enhance the performance, biocompatibility, and safety of medical tubing. These advancements attract investment and drive the market growth as healthcare providers seek cutting-edge solutions. For instance, in March 2022, Shockwave Medical, Inc., received FDA permission and introduced the Shockwave M5+ peripheral IVL catheter. The Shockwave M5+ catheter is specifically developed to reduce Intravascular Lithotripsy (IVL) treatment time, offer alternate access options, and expand IVL therapy to patients with bigger vessel diameters.
The market research report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include: